AvantGen

company

About

AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions.

  • 1 - 10

Details

Last Funding Type
Grant
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 2006
Number Of Employee
1 - 10
Operating Status
Active

AvantGen is a San Diego-based biotechnology company founded in 2006 with Therapeutic and Research & Diagnostic divisions. Its Therapeutic Division is dedicated to novel human antibody discovery, antibody humanization, antibody affinity maturation and optimization for therapeutic development. AvantGen has a proprietary and robust yeast display system, large natural human antibody database, fully human antibody (Germliner™) libraries and screening technologies and collaborates with pharmaceutical and biotechnology companies to facilitate and speed their path to antibody-based therapeutic development through services, partnerships, and licensing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
AvantGen has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 25, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 25, 2021 Grant 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
AvantGen is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant